Related Experiment Video
Updated: Nov 10, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Non-Coding RNAs as Prognostic Markers for Endometrial Cancer
Roberto Piergentili1, Simona Zaami2, Anna Franca Cavaliere3
1Institute of Molecular Biology and Pathology, Italian National Research Council (CNR-IBPM), 00185 Rome, Italy.
Noncoding RNAs (ncRNAs) show promise as prognostic markers for endometrial cancer (EC). Further research into their genetic and epigenetic roles could enhance current diagnostic and therapeutic tools for EC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Endometrial cancer (EC) classification has evolved from clinical and pathological features to include genetic and epigenetic aspects.
- Emerging research highlights the significance of noncoding RNAs (ncRNAs) in various cancers, including EC.
Purpose of the Study:
- To review the importance of genetic and epigenetic events in endometrial cancer tumorigenesis.
- To expound upon the prognostic role of ncRNAs in endometrial cancer.
Main Methods:
- Literature review focusing on genetic and epigenetic factors in EC.
- Analysis of current research on ncRNAs and their association with EC prognosis.
Main Results:
- Genetic and epigenetic alterations are crucial in EC development.
- Noncoding RNAs (ncRNAs) are increasingly recognized for their potential as prognostic markers in EC.
Conclusions:
- ncRNAs represent promising biomarkers for endometrial cancer.
- The integration of ncRNA analysis with existing prognostic tools may improve EC patient management.
More Related Videos
08:12Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs